Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H12FN3O3 |
| Molecular Weight | 313.2832 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O\C(=C/C(=O)C1=CC=C(CC2=CC=C(F)C=C2)O1)C3=NNC=N3
InChI
InChIKey=HFHDGHOGHWXXDT-ZSOIEALJSA-N
InChI=1S/C16H12FN3O3/c17-11-3-1-10(2-4-11)7-12-5-6-15(23-12)13(21)8-14(22)16-18-9-19-20-16/h1-6,8-9,22H,7H2,(H,18,19,20)/b14-8-
| Molecular Formula | C16H12FN3O3 |
| Molecular Weight | 313.2832 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
GW-810781 (wider known as S-1360) was initially developed by GlaxoSmithKline as HIV integrase inhibitor. GW-810781 was well-tolerated and showed acceptable pharmacokinetic profiles that is why it was studied in phase II clinical trials as a potential treatment for HIV infection. However, the development of the drug was discontinued in July 2003.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis, docking, and biological studies of phenanthrene β-diketo acids as novel HIV-1 integrase inhibitors. | 2013-11-15 |
|
| HIV-1 IN strand transfer chelating inhibitors: a focus on metal binding. | 2011-04-04 |
|
| Potent inhibitors of HIV-1 integrase display a two-step, slow-binding inhibition mechanism which is absent in a drug-resistant T66I/M154I mutant. | 2009-02-24 |
|
| Synthesis and biological evaluation of novel 5(H)-phenanthridin-6-ones, 5(H)-phenanthridin-6-one diketo acid, and polycyclic aromatic diketo acid analogs as new HIV-1 integrase inhibitors. | 2007-02-01 |
|
| A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores. | 2006-12-15 |
|
| Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore. | 2006-07 |
|
| HIV integrase inhibitors with nucleobase scaffolds: discovery of a highly potent anti-HIV agent. | 2006-01-26 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:12:57 GMT 2025
by
admin
on
Mon Mar 31 18:12:57 GMT 2025
|
| Record UNII |
W7KQU075CV
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
280571-30-4
Created by
admin on Mon Mar 31 18:12:57 GMT 2025 , Edited by admin on Mon Mar 31 18:12:57 GMT 2025
|
PRIMARY | |||
|
(Z)-1-(5-(4-FLUOROBENZYL)FURAN-2-YL)-3-HYDROXY-3-(1H-1,2,4-TRIAZOL-3-YL)-PROPENONE
Created by
admin on Mon Mar 31 18:12:57 GMT 2025 , Edited by admin on Mon Mar 31 18:12:57 GMT 2025
|
PRIMARY | |||
|
100000167469
Created by
admin on Mon Mar 31 18:12:57 GMT 2025 , Edited by admin on Mon Mar 31 18:12:57 GMT 2025
|
PRIMARY | |||
|
SUB181661
Created by
admin on Mon Mar 31 18:12:57 GMT 2025 , Edited by admin on Mon Mar 31 18:12:57 GMT 2025
|
PRIMARY | |||
|
W7KQU075CV
Created by
admin on Mon Mar 31 18:12:57 GMT 2025 , Edited by admin on Mon Mar 31 18:12:57 GMT 2025
|
PRIMARY | |||
|
6451047
Created by
admin on Mon Mar 31 18:12:57 GMT 2025 , Edited by admin on Mon Mar 31 18:12:57 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
